European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

Merck Announces New Appointments in Global R&D and Strategy Leadership for Healthcare Business Sector

by Marie Weil
January 14, 2022
A A
Share on LinkedinShare on Twitter

Merck today announced new appointments in Global R&D and Strategy leadership for the Healthcare business sector.

Darmstadt, Germany, January 13, 2022 – Merck, a leading science and technology company, today announced new appointments in Global R&D and Strategy leadership for the Healthcare business sector. Danny Bar-Zohar, MD, will become Global Head of R&D and Joern-Peter Halle, PhD, will become Chief Strategy Officer.

“At the critical intersection of R&D and Strategy is a very unique opportunity to make bold choices that best position us to deliver on our fullest innovative potential for patients and for Merck,” said Peter Guenter, Member of the Executive Board of Merck, and CEO Healthcare. “With Danny and Joern-Peter, we have the perfect combination of collaboration, strategic vision and leadership, in addition to world-class experience and expertise, to move beyond the status quo and lead our innovation engine for today and for the future.”

As Global Head of R&D, Bar-Zohar will lead Research and Development, including Medical Affairs. Bar-Zohar joined Merck in November 2020 as Executive Vice President, Global Head of Development. He has more than a decade of leadership experience in pharma, having worked previously at Novartis and Teva. He brings global drug development experience from strategy to execution to this position, across almost every modality in drug development, including small molecules, therapeutic proteins, antibodies and gene therapy. Bar-Zohar’s proven track record will serve to further advance the highly innovative and differentiated early-stage assets the Merck research teams have delivered into development in recent years.

As Chief Strategy Officer, Halle will lead Strategy and Business Development. Halle brings significant experience to this role, having previously served as Executive Vice President, Global Head of Research for the last 18 months, leading discovery through pre-clinical efforts for the company’s Oncology/Immuno-Oncology and Immunology therapeutic areas. Halle also served as Senior Vice President, Head of Immuno-Oncology research, and Senior Vice President, Head of External Innovation. Halle brings more than 25 years of industry experience to this position. He joined Merck in 2005.

Both Bar-Zohar and Halle will continue to be part of the Healthcare Executive Committee and be based at the company’s global headquarters in Darmstadt, Germany.

Tags: < PEOPLE

Related Industries

Health

Interview with Mr. Sébastien Huron, CEO, Virbac group

March 6, 2023
Health

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

February 23, 2023
Health

Philips recognized as top innovator for 10th consecutive year

February 17, 2023
Health

Bayer completes acquisition of Blackford Analysis Ltd.

February 14, 2023
Health

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

January 25, 2023
Health

Aleksandra Rizo Appointed as CEO of Vividion Therapeutics

January 25, 2023

Huawei’s Green Target Network and 5G Smart Ocean Projects Win Multiple GTI Awards

March 4, 2023

...

Carrier Makes Donation to the European Food Banks Federation to Help Reduce Food Insecurity in Europe

March 8, 2023

...

Henkel launches novel Sensor INKxperience Kit for IOT sensor engineering with printed electronics technologies

February 23, 2023

...

TÜV SÜD APPOINTS GERALD BACHLER AS NEW CEO OF THE CENTRAL & EASTERN EUROPE (CEE) REGION

March 2, 2023

...

ABN AMRO Sustainable Impact Fund invests in Fairphone

February 25, 2023

...

Interview with Mr. Sébastien Huron, CEO, Virbac group

March 6, 2023

...

Joachim Aelvoet is the new Country Executive of ABN AMRO in Belgium

March 9, 2023

...

BASF and Tenova Advanced Technologies enter into a joint development agreement for efficient recycling of lithium-ion batteries

February 23, 2023

...

Amazon named as a “Top Employer 2023” in Europe

March 1, 2023

...

Xiaomi Begins Product Carbon Footprint Assessment and Champions Sustainable Living Awareness

February 27, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist